COLL - Collegium Pharmaceutical Non-GAAP EPS of $1.32 misses by $0.19 revenue of $144.8M beats by $6.47M
2023-05-04 17:00:28 ET
- Collegium Pharmaceutical press release ( NASDAQ: COLL ): Q1 Non-GAAP EPS of $1.32 misses by $0.19 .
- Revenue of $144.8M (+72.9% Y/Y) beats by $6.47M .
- FY23 Product Revenues, Net expected in the range of $565.0 to $580.0 million, Adjusted Operating Expenses of $135.0 to $145.0 million and Adjusted EBITDA of $355.0 to $370.0 million.
- Shares +5.86% .
For further details see:
Collegium Pharmaceutical Non-GAAP EPS of $1.32 misses by $0.19, revenue of $144.8M beats by $6.47M